Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|March 7, 2012
Approach to the hypophosphatemic patientErik A Imel, Michael J EconsPediatric Endocrinology Reviews : PER|November 21, 2007
Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23Erik A Imel, Michael J EconsJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 18, 2007
FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic ricketsErik A Imel, Siu L Hui, Michael J EconsBone|December 12, 2013
Iron and fibroblast growth factor 23 in X-linked hypophosphatemiaErik A Imel, Amie K Gray, Leah R Padgett, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 26, 2019
Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic RicketsErik A Imel, Ziyue Liu, Melissa Coffman, et al.The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrationsErik A Imel, Linda A DiMeglio, Siu L Hui, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2019
Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant OsteopetrosisErik A Imel, Ziyue Liu, Dena Acton, et al.The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuriaShoji Ichikawa, Andrea H Sorenson, Erik A Imel, et al.The Journal of Clinical Endocrinology and Metabolism|September 2, 2011
Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humansErik A Imel, Munro Peacock, Amie K Gray, et al.Pageof 20